ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Canine Arthritis Therapeutics Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-7H14517
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Canine Arthritis Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Canine Arthritis Therapeutics Market Research Report 2025

Code: QYRE-Auto-7H14517
Report
July 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boehringer Ingelheim
Zoetis Inc
Vetoquinol
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VETSTEM BIOPHARMA
Dechra Pharmaceuticals Plc
Elanco

Canine Arthritis Therapeutics Market Size

The global market for Canine Arthritis Therapeutics was valued at US$ 2583 million in the year 2024 and is projected to reach a revised size of US$ 3431 million by 2031, growing at a CAGR of 4.2% during the forecast period.

Canine Arthritis Therapeutics Market

Canine Arthritis Therapeutics Market

The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. 
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
This report aims to provide a comprehensive presentation of the global market for Canine Arthritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Arthritis Therapeutics.
The Canine Arthritis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Canine Arthritis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Canine Arthritis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Canine Arthritis Therapeutics Market Report

Report Metric Details
Report Name Canine Arthritis Therapeutics Market
Accounted market size in year US$ 2583 million
Forecasted market size in 2031 US$ 3431 million
CAGR 4.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Veterinary Hospitals and Clinics
  • Retail Pharmacies
  • Drug Stores
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim, Zoetis Inc, Vetoquinol S.A., Elanco, Aratana Therapeutics Inc, Norbrook Laboratories Limited, VetStem Biopharma, Dechra Pharmaceuticals Plc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Canine Arthritis Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Canine Arthritis Therapeutics Market growing?

Ans: The Canine Arthritis Therapeutics Market witnessing a CAGR of 4.2% during the forecast period 2025-2031.

What is the Canine Arthritis Therapeutics Market size in 2031?

Ans: The Canine Arthritis Therapeutics Market size in 2031 will be US$ 3431 million.

Who are the main players in the Canine Arthritis Therapeutics Market report?

Ans: The main players in the Canine Arthritis Therapeutics Market are Boehringer Ingelheim, Zoetis Inc, Vetoquinol S.A., Elanco, Aratana Therapeutics Inc, Norbrook Laboratories Limited, VetStem Biopharma, Dechra Pharmaceuticals Plc

What are the Application segmentation covered in the Canine Arthritis Therapeutics Market report?

Ans: The Applications covered in the Canine Arthritis Therapeutics Market report are Veterinary Hospitals and Clinics, Retail Pharmacies, Drug Stores

What are the Type segmentation covered in the Canine Arthritis Therapeutics Market report?

Ans: The Types covered in the Canine Arthritis Therapeutics Market report are Non-Steroidal Anti-Inflammatory Drugs, Opioids, Stem Cell Therapy

Recommended Reports

Dog Pain & Arthritis

Veterinary Drugs

Dog Health Supplements

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Arthritis Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Non-Steroidal Anti-Inflammatory Drugs
1.2.3 Opioids
1.2.4 Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Canine Arthritis Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Veterinary Hospitals and Clinics
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Canine Arthritis Therapeutics Market Perspective (2020-2031)
2.2 Global Canine Arthritis Therapeutics Growth Trends by Region
2.2.1 Global Canine Arthritis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Canine Arthritis Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Canine Arthritis Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Canine Arthritis Therapeutics Market Dynamics
2.3.1 Canine Arthritis Therapeutics Industry Trends
2.3.2 Canine Arthritis Therapeutics Market Drivers
2.3.3 Canine Arthritis Therapeutics Market Challenges
2.3.4 Canine Arthritis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Canine Arthritis Therapeutics Players by Revenue
3.1.1 Global Top Canine Arthritis Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Canine Arthritis Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Canine Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Canine Arthritis Therapeutics Revenue
3.4 Global Canine Arthritis Therapeutics Market Concentration Ratio
3.4.1 Global Canine Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Arthritis Therapeutics Revenue in 2024
3.5 Global Key Players of Canine Arthritis Therapeutics Head office and Area Served
3.6 Global Key Players of Canine Arthritis Therapeutics, Product and Application
3.7 Global Key Players of Canine Arthritis Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Canine Arthritis Therapeutics Breakdown Data by Type
4.1 Global Canine Arthritis Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Canine Arthritis Therapeutics Forecasted Market Size by Type (2026-2031)
5 Canine Arthritis Therapeutics Breakdown Data by Application
5.1 Global Canine Arthritis Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Canine Arthritis Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Canine Arthritis Therapeutics Market Size (2020-2031)
6.2 North America Canine Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Canine Arthritis Therapeutics Market Size by Country (2020-2025)
6.4 North America Canine Arthritis Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Canine Arthritis Therapeutics Market Size (2020-2031)
7.2 Europe Canine Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Canine Arthritis Therapeutics Market Size by Country (2020-2025)
7.4 Europe Canine Arthritis Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Canine Arthritis Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Canine Arthritis Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Canine Arthritis Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Canine Arthritis Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Canine Arthritis Therapeutics Market Size (2020-2031)
9.2 Latin America Canine Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Canine Arthritis Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Canine Arthritis Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Canine Arthritis Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Canine Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Canine Arthritis Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Canine Arthritis Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Canine Arthritis Therapeutics Introduction
11.1.4 Boehringer Ingelheim Revenue in Canine Arthritis Therapeutics Business (2020-2025)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Zoetis Inc
11.2.1 Zoetis Inc Company Details
11.2.2 Zoetis Inc Business Overview
11.2.3 Zoetis Inc Canine Arthritis Therapeutics Introduction
11.2.4 Zoetis Inc Revenue in Canine Arthritis Therapeutics Business (2020-2025)
11.2.5 Zoetis Inc Recent Development
11.3 Vetoquinol S.A.
11.3.1 Vetoquinol S.A. Company Details
11.3.2 Vetoquinol S.A. Business Overview
11.3.3 Vetoquinol S.A. Canine Arthritis Therapeutics Introduction
11.3.4 Vetoquinol S.A. Revenue in Canine Arthritis Therapeutics Business (2020-2025)
11.3.5 Vetoquinol S.A. Recent Development
11.4 Elanco
11.4.1 Elanco Company Details
11.4.2 Elanco Business Overview
11.4.3 Elanco Canine Arthritis Therapeutics Introduction
11.4.4 Elanco Revenue in Canine Arthritis Therapeutics Business (2020-2025)
11.4.5 Elanco Recent Development
11.5 Aratana Therapeutics Inc
11.5.1 Aratana Therapeutics Inc Company Details
11.5.2 Aratana Therapeutics Inc Business Overview
11.5.3 Aratana Therapeutics Inc Canine Arthritis Therapeutics Introduction
11.5.4 Aratana Therapeutics Inc Revenue in Canine Arthritis Therapeutics Business (2020-2025)
11.5.5 Aratana Therapeutics Inc Recent Development
11.6 Norbrook Laboratories Limited
11.6.1 Norbrook Laboratories Limited Company Details
11.6.2 Norbrook Laboratories Limited Business Overview
11.6.3 Norbrook Laboratories Limited Canine Arthritis Therapeutics Introduction
11.6.4 Norbrook Laboratories Limited Revenue in Canine Arthritis Therapeutics Business (2020-2025)
11.6.5 Norbrook Laboratories Limited Recent Development
11.7 VetStem Biopharma
11.7.1 VetStem Biopharma Company Details
11.7.2 VetStem Biopharma Business Overview
11.7.3 VetStem Biopharma Canine Arthritis Therapeutics Introduction
11.7.4 VetStem Biopharma Revenue in Canine Arthritis Therapeutics Business (2020-2025)
11.7.5 VetStem Biopharma Recent Development
11.8 Dechra Pharmaceuticals Plc
11.8.1 Dechra Pharmaceuticals Plc Company Details
11.8.2 Dechra Pharmaceuticals Plc Business Overview
11.8.3 Dechra Pharmaceuticals Plc Canine Arthritis Therapeutics Introduction
11.8.4 Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Therapeutics Business (2020-2025)
11.8.5 Dechra Pharmaceuticals Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Boehringer Ingelheim
Zoetis Inc
Vetoquinol
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VETSTEM BIOPHARMA
Dechra Pharmaceuticals Plc
Elanco
List of Tables
 Table 1. Global Canine Arthritis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Non-Steroidal Anti-Inflammatory Drugs
 Table 3. Key Players of Opioids
 Table 4. Key Players of Stem Cell Therapy
 Table 5. Global Canine Arthritis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Canine Arthritis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Canine Arthritis Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Canine Arthritis Therapeutics Market Share by Region (2020-2025)
 Table 9. Global Canine Arthritis Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Canine Arthritis Therapeutics Market Share by Region (2026-2031)
 Table 11. Canine Arthritis Therapeutics Market Trends
 Table 12. Canine Arthritis Therapeutics Market Drivers
 Table 13. Canine Arthritis Therapeutics Market Challenges
 Table 14. Canine Arthritis Therapeutics Market Restraints
 Table 15. Global Canine Arthritis Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Canine Arthritis Therapeutics Market Share by Players (2020-2025)
 Table 17. Global Top Canine Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Therapeutics as of 2024)
 Table 18. Ranking of Global Top Canine Arthritis Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Canine Arthritis Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Canine Arthritis Therapeutics, Headquarters and Area Served
 Table 21. Global Key Players of Canine Arthritis Therapeutics, Product and Application
 Table 22. Global Key Players of Canine Arthritis Therapeutics, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Canine Arthritis Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Canine Arthritis Therapeutics Revenue Market Share by Type (2020-2025)
 Table 26. Global Canine Arthritis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Canine Arthritis Therapeutics Revenue Market Share by Type (2026-2031)
 Table 28. Global Canine Arthritis Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Canine Arthritis Therapeutics Revenue Market Share by Application (2020-2025)
 Table 30. Global Canine Arthritis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Canine Arthritis Therapeutics Revenue Market Share by Application (2026-2031)
 Table 32. North America Canine Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Canine Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Canine Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Canine Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Canine Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Canine Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Canine Arthritis Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Canine Arthritis Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Canine Arthritis Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Canine Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Canine Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Canine Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Canine Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Canine Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Canine Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Boehringer Ingelheim Company Details
 Table 48. Boehringer Ingelheim Business Overview
 Table 49. Boehringer Ingelheim Canine Arthritis Therapeutics Product
 Table 50. Boehringer Ingelheim Revenue in Canine Arthritis Therapeutics Business (2020-2025) & (US$ Million)
 Table 51. Boehringer Ingelheim Recent Development
 Table 52. Zoetis Inc Company Details
 Table 53. Zoetis Inc Business Overview
 Table 54. Zoetis Inc Canine Arthritis Therapeutics Product
 Table 55. Zoetis Inc Revenue in Canine Arthritis Therapeutics Business (2020-2025) & (US$ Million)
 Table 56. Zoetis Inc Recent Development
 Table 57. Vetoquinol S.A. Company Details
 Table 58. Vetoquinol S.A. Business Overview
 Table 59. Vetoquinol S.A. Canine Arthritis Therapeutics Product
 Table 60. Vetoquinol S.A. Revenue in Canine Arthritis Therapeutics Business (2020-2025) & (US$ Million)
 Table 61. Vetoquinol S.A. Recent Development
 Table 62. Elanco Company Details
 Table 63. Elanco Business Overview
 Table 64. Elanco Canine Arthritis Therapeutics Product
 Table 65. Elanco Revenue in Canine Arthritis Therapeutics Business (2020-2025) & (US$ Million)
 Table 66. Elanco Recent Development
 Table 67. Aratana Therapeutics Inc Company Details
 Table 68. Aratana Therapeutics Inc Business Overview
 Table 69. Aratana Therapeutics Inc Canine Arthritis Therapeutics Product
 Table 70. Aratana Therapeutics Inc Revenue in Canine Arthritis Therapeutics Business (2020-2025) & (US$ Million)
 Table 71. Aratana Therapeutics Inc Recent Development
 Table 72. Norbrook Laboratories Limited Company Details
 Table 73. Norbrook Laboratories Limited Business Overview
 Table 74. Norbrook Laboratories Limited Canine Arthritis Therapeutics Product
 Table 75. Norbrook Laboratories Limited Revenue in Canine Arthritis Therapeutics Business (2020-2025) & (US$ Million)
 Table 76. Norbrook Laboratories Limited Recent Development
 Table 77. VetStem Biopharma Company Details
 Table 78. VetStem Biopharma Business Overview
 Table 79. VetStem Biopharma Canine Arthritis Therapeutics Product
 Table 80. VetStem Biopharma Revenue in Canine Arthritis Therapeutics Business (2020-2025) & (US$ Million)
 Table 81. VetStem Biopharma Recent Development
 Table 82. Dechra Pharmaceuticals Plc Company Details
 Table 83. Dechra Pharmaceuticals Plc Business Overview
 Table 84. Dechra Pharmaceuticals Plc Canine Arthritis Therapeutics Product
 Table 85. Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Therapeutics Business (2020-2025) & (US$ Million)
 Table 86. Dechra Pharmaceuticals Plc Recent Development
 Table 87. Research Programs/Design for This Report
 Table 88. Key Data Information from Secondary Sources
 Table 89. Key Data Information from Primary Sources
 Table 90. Authors List of This Report


List of Figures
 Figure 1. Canine Arthritis Therapeutics Picture
 Figure 2. Global Canine Arthritis Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Canine Arthritis Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. Non-Steroidal Anti-Inflammatory Drugs Features
 Figure 5. Opioids Features
 Figure 6. Stem Cell Therapy Features
 Figure 7. Global Canine Arthritis Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Canine Arthritis Therapeutics Market Share by Application: 2024 VS 2031
 Figure 9. Veterinary Hospitals and Clinics Case Studies
 Figure 10. Retail Pharmacies Case Studies
 Figure 11. Drug Stores Case Studies
 Figure 12. Canine Arthritis Therapeutics Report Years Considered
 Figure 13. Global Canine Arthritis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Canine Arthritis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Canine Arthritis Therapeutics Market Share by Region: 2024 VS 2031
 Figure 16. Global Canine Arthritis Therapeutics Market Share by Players in 2024
 Figure 17. Global Top Canine Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Therapeutics as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Canine Arthritis Therapeutics Revenue in 2024
 Figure 19. North America Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Canine Arthritis Therapeutics Market Share by Country (2020-2031)
 Figure 21. United States Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Canine Arthritis Therapeutics Market Share by Country (2020-2031)
 Figure 25. Germany Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Canine Arthritis Therapeutics Market Share by Region (2020-2031)
 Figure 33. China Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Canine Arthritis Therapeutics Market Share by Country (2020-2031)
 Figure 41. Mexico Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Canine Arthritis Therapeutics Market Share by Country (2020-2031)
 Figure 45. Turkey Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Canine Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Boehringer Ingelheim Revenue Growth Rate in Canine Arthritis Therapeutics Business (2020-2025)
 Figure 49. Zoetis Inc Revenue Growth Rate in Canine Arthritis Therapeutics Business (2020-2025)
 Figure 50. Vetoquinol S.A. Revenue Growth Rate in Canine Arthritis Therapeutics Business (2020-2025)
 Figure 51. Elanco Revenue Growth Rate in Canine Arthritis Therapeutics Business (2020-2025)
 Figure 52. Aratana Therapeutics Inc Revenue Growth Rate in Canine Arthritis Therapeutics Business (2020-2025)
 Figure 53. Norbrook Laboratories Limited Revenue Growth Rate in Canine Arthritis Therapeutics Business (2020-2025)
 Figure 54. VetStem Biopharma Revenue Growth Rate in Canine Arthritis Therapeutics Business (2020-2025)
 Figure 55. Dechra Pharmaceuticals Plc Revenue Growth Rate in Canine Arthritis Therapeutics Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Canine Arthritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pet NSAIDs Market Research Report 2025
Global Pets NSAIDs Market Research Report 2025
Arthritis Treatment Medicine for Dogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti inflammatory Medicine for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Carprofen Market Research Report 2025
Global Reagent Grade Firocoxib Market Research Report 2024
Global Canine Stem Cell Therapy Market Research Report 2024
Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025
Global Stem Cell Therapy for Pets Market Research Report 2024
Anti inflammatory Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030
Global Canine Orthopedic Implants Market Research Report 2025
Global Pet Arthritis Market Research Report 2025
Global Steroids for Pets Market Research Report 2025
Global Animal Stem Cell Therapy Market Research Report 2025
Global Small Companion Animal Drug Market Research Report 2024
Global Companion Animal Arthritis Market Research Report 2025
Global Anti inflammatory Therapeutics Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Anthelmintics for Dogs and Cats Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions